References
- Criscuoli M., Lippi A., Mengozzi G., Sardelli G., Subissi A., Giachetti A. Pharmacokinetics and pharmacodynamics of idrapril in rats, dogs and humans. Drug Metabolism Disposition 1993; 21: 835–840
- Fishbein W. A., Streeter C. L. Physiological disposition of short chain aliphatic hydroxamates in the mouse. I. The one-through-four carbon hydroxamates: excretion and conversion to amides. Journal of Pharmacology and Experimental Therapeutics 1970; 174: 239–248
- Hirao Y., Kitamura S., Tatsumi K. Epoxide reductase activity of mammalian liver cytosols and aldehyde oxidase. Carcinogenesis 1994; 15: 739–743
- Lippi A., Criscuoli M., Sardelli G., Subissi A. Inhibition of rabbit lung angiotensin converting enzyme by idrapril. Biochemical Pharmacology 1993; 45: 1358–1362
- Lippi A., Criscuoli M., Sardelli G., Subissi A. A high-performance liquid chromatography method with electrochemical detection for the determination of idrapril, a novel ACE inhibitor, in biological matrices. Journal of Chromatography 1994; 660: 127–134
- Putcha L., Griffith D. P., Feldman S. Disposition of 14C-acetohydroxamic acid and 14C-acetamide in the rat. Drug Metabolism and Disposition 1984; 12: 438–443
- Sica D. A. Kinetics of ACE inhibitors in renal failure. Journal of Cardiovascular Pharmacology 1992; 20: S13–20
- Subissi A., Criscuoli M., Sardelli G., Guelfi M., Giachetti A. Pharmacology of idrapril: a new class of angiotensin converting enzyme inhibitors. Journal of Cardiovascular Pharmacology 1992; 20: 139–146
- Sugihara K., Tatsumi K. Participation of liver aldehyde oxidase in reductive metabolism of hydroxamic acids to amides. Archives of Biochemistry and Biophysics 1986; 247: 289–293
- Tatsumi K., Kitamura S., Narai N. Reductive metabolism of aromatic nitro compounds including carcinogens by rabbit liver preparations. Cancer Research 1986; 46: 1089–1093
- Turbanti L., Cerbai G., Di Bugno C., Giorgi R., Garzelli G., Criscuoli M., Renzetti A. R., Subissi A., Bramanti G., DePriest S. A. 1,2-Cyclomethylene-carboxylic mono-amide hydroxamyc derivatives. A novel class of non-aminoacid angiotensin converting enzyme inhibitors. Journal of Medicinal Chemistry 1993; 36: 699–707
- Zanchi A., Nussberger J., Criscuoli M., Capone P., Brunner H. R. ACE inhibition by hydroxamic zinc binding idrapril in humans. Journal of Cardiovascular Pharmacology 1994; 24: 317–322
- Wyld P. J., Grant J., Lippi A., Criscuoli M., Del Re G., Subissi A. Pharmacokinetics and biochemical efficacy of idrapril calcium, a novel ACE inhibitor, after multiple oral administration in humans. British Journal of Clinical Pharmacology 1994; 38: 421–425